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Abstract: Mineral bone cements were actually not developed for their application as bone-bonding
agents, but as bone void fillers. In particular, calcium phosphate cements (CPC) are considered to
be unsuitable for that application, particularly under moist conditions. Here, we showed the ex
vivo ability of different magnesium phosphate cements (MPC) to adhere on bovine cortical bone
substrates. The cements were obtained from a mixture of farringtonite (Mg3(PO4)2) with different
amounts of phytic acid (C6H18O24P6, inositol hexaphosphate, IP6), whereas cement setting occurred
by a chelation reaction between Mg2+ ions and IP6. We were able to show that cements with 25%
IP6 and a powder-to-liquid ratio (PLR) of 2.0 g/mL resulted in shear strengths of 0.81 ± 0.12 MPa on
bone even after 7 d storage in aqueous conditions. The samples showed a mixed adhesive–cohesive
failure with cement residues on the bone surface as indicated by scanning electron microscopy
and energy-dispersive X-ray analysis. The presented material demonstrated appropriate bonding
characteristics, which could enable a broadening of the mineral bone cements’ application field to
bone adhesives.
Keywords: magnesium phosphate cement; phytic acid; bone adhesive
1. Introduction
There are two main indications for the application of bone adhesives: one is to joint bone fragments
of comminuted fractures as a bone-to-bone interface. This allows the partial substitution of fracture
fixation by metal components such as wires, screws, and plates especially for small fragments with a
size of < 1 cm [1]. Furthermore, bone adhesives can serve as an additional bone-to-metal interface
for metallic alloys [2]. An application for such indications would require appropriate adhesion to
both bone as well as metal compartments. In particular, in the first case, the adhesive material
must not impair fracture healing by forming a rigid barrier, which is enabled while applying the
bone adhesive only selectively or by using biodegradable materials. Recent approaches to create
bone adhesives include cyanoacrylates [3,4], methacrylates [5–7], fibrin glue [8], mussel proteins and
dopamine hydrogels [9–11], or polysaccharides [12–14]. Most synthetic materials that have been tested
as bone-bonding agents, are either mechanically weak with insufficient adhesion to the bone surface or
do not fulfill the requirement of biodegradability, as for example poly(methyl methacrylate) (PMMA),
cyanoacrylates and its associated formulations [15].
In contrast, mineral bone cement formulations based on calcium and magnesium phosphate
chemistry (CPC and MPC) are biodegradable in vivo [16,17], but were actually not developed for
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the application as bone adhesives. In particular CPC are considered to have relatively low bone
adhesiveness [15], why most research focused on the implementation of calcium phosphate fillers into
methacrylated polymer-based composite systems [18–20]. Compared to CPC, some of the material
characteristics of MPC are outstanding, which includes their high initial strength [21], a more reliable
degradation potential [16,17] and they are considered to have a higher bone affinity [15,22].
In the present study, we chose a MPC in which farringtonite (Mg3(PO4)2) reacted with phytic
acid (C6H18O24P6, inositol hexaphosphate, IP6) via a chelation mechanism to form a stable complexed
magnesium phosphate cement [23]. During our previous work on this system we observed a high
adhesiveness of this cement type to the surfaces of tools such as glass slabs, spatula, or molds. This
was further explored in the current study to cortical bone substrates to determine the adhesiveness ex
vivo in a shear test regime. We hypothesized that the phytic acid will be the reason for the cement
formulation to show a higher bone affinity compared to conventional mineral bone cements, as phytic
acid is able to form insoluble complexes with calcium [24,25] and magnesium cations [20], which are
contained in the raw powder (Mg) as well as in the used bone slices [26].
2. Materials and Methods
2.1. Cement Preparation
0.6 mol MgHPO4·3H2O (newberyite) was mixed with 0.3 mol Mg(OH)2 and tempered for 5 h in a
sintering oven (Oyten Thermotechnic, Oyten, Germany) at 1100 ◦C. The sintered cake was crushed,
sieved < 355 µm and milled in a planetary ball mill (Retsch, Haan, Germany) for 1 h at 200 rpm.
The resulting raw powder Mg3(PO4)2 (farringtonite) was compounded with different amounts of
MgO Magnesia 2933 (6.0 wt.%, 6.8 wt.% or 7.5 wt.%; Magnesia, Lüneburg, Germany) and mixed with
variably concentrated phytic acid solution (C6H18O24P6, 20.0%, 22.5% or 25%) in a powder-to-liquid
ratio (PLR) of 2.0 g/mL. Low MgO amounts were combined with low phytic acid concentration and
vice versa. Mg3(PO4)2 was blended with 2.0 M phosphoric acid (H3PO4, Merck, Darmstadt, Germany)
with a PLR of 2.0 g/mL for reference measurements. If not else described, all chemicals originate from
Sigma Aldrich, Steinheim, Germany.
2.2. Compressive Strength Testing
The cement pastes were transferred into silicone rubber molds (6 × 6 × 12 mm3), stored for 1 h at
37 ◦C and > 90% humidity, demolded, covered with phosphate buffered saline (PBS, 8.0 g/L NaCl,
1.1 g/L Na2HPO4, 0.2 g/L KCl, 1.1 g/L KH2PO4; potassium salts purchased from Merck, Darmstadt,
Germany, and sodium salts purchased from Sigma Aldrich, Steinheim, Germany; pH = 7.4) and stored
at 37 ◦C. The wet compressive strengths of the cuboids (n = 12) was measured 24 h respectively 7 d
after fabrication. In the latter case, PBS was changed twice. For initial mechanical testing, the samples
were directly analyzed after demolding. A universal testing machine Z010 (Zwick, Ulm, Germany)
was used at a crosshead speed of 1 mm/min.
2.3. Phase Composition
The cement fragments were ground and further analyzed via X-ray diffractometer (XRD) D5005
(Siemens, Karlsruhe, Germany). Cu-Kα radiation, a 40 kV voltage, a 40 mA current, a 2 theta range
from 20 to 40◦, a step size of 0.02◦ and a scan rate of 1.5 s/step were used. Joint Committee on Powder
Diffraction Standards (JCPDS) references were considered for XRD pattern evaluation.
2.4. Adhesion Testing
For measuring the cement adhesion to bone, ~3 mm × 10 mm × 20 mm cortical bone samples
were prepared from fresh bovine femurs by sawing and grinding their surface with SiC-paper (grit P80,
Schmitz-Metallographie, Herzogenrath, Germany). A disc-shaped silicone rubber mold (2 × 5 mm2)
was fastened centrically onto a bovine bone substrate and filled with the as-prepared cement paste.
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After 10 min, the samples were demolded such that the cement disc directly stuck on the bone surface.
The shear force as a measure for bone adhesiveness (n = 5) was tested via universal testing machine
Z010 (Zwick, Ulm, Germany) with a crosshead speed of 1 mm/min in the dry state after fabrication
(initial adhesiveness) and after further immersion for 24 h respectively 7 d in PBS at 37 ◦C. For the 7 d
deposition in PBS, the buffer was changed twice. When the samples dropped off before measurement,
the shear strength was set to zero, when the samples dropped off because of the net weight (66.23 g) of
the stamp, this weight was taken into account for further shear strength calculations. For all other
samples, the net weight of the stamp was also added to the maximum force and consequently included
in shear strength calculations.
2.5. Scanning Electron Microscopy and Energy-Dispersive X-ray Spectroscopy
After having tested the adhesiveness, cement residues were visualized by scanning electron
microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). The bone slices were dried by
immersion in mixtures of acetone with ultrapure water (30, 50, 70, 90 and 6 × 100%) for 1 h respectively,
followed by super-critical drying with the device CPD 030 (Bal-Tec, Balzers, Liechtenstein). First, the
acetone was exchanged by liquid CO2 at a temperature of 6 to 11 ◦C (10 exchange cycles), followed by
an evaporation of CO2 at 42 ◦C. Afterwards, the bone surfaces were sputtered with a 4 nm platinum
layer (Leica EM ACE600, Leica Microsystems, Wetzlar, Germany). The morphology of adhesive
residues was determined with a scanning electron microscope Crossbeam 340 (SEM, Zeiss, Oberkochen,
Germany). Furthermore, EDS was performed with an INCA Energy 350 AzTec Advanced system
using a silicon drift detector (SDD) (Oxford Instruments, Abingdon, UK) for element mapping with a
resolution of 512, 10 frames, a process time of 4, a pixel retention time of 10 µs, a 60 µm slit and a high
voltage of 20 kV. For semi-quantitative evaluations of corresponding Ca-to-Mg-ratios, the percentaged
amount of Ca and Mg was calculated based on the border EDS element maps. For each region (cement,
adherend), three ellipsoid sectors were analyzed each.
2.6. Statistics
Significant differences (p < 0.01) were calculated using a 1-way ANOVA (inerSTAT-a v1.3, M.H.
Vargas, Instituto Nacional de Enfermedad Respiratorias, Mexico).
3. Results
We determined the intrinsic material strength via a compressive strength test setup (Figure 1).
Obviously, the phytic acid containing samples had a significant higher compressive strength at every
measured time point compared to the reference. Only those samples with a 25.0% phytic acid amount
had an initial strength after 1 h setting of 2.29 ± 1.76 MPa which was comparable to the reference
strength (2.21 ± 1.76 MPa). In the course of 7 d, the reference compressive strength increased by 305%
up to 8.95 ± 1.84 MPa, while the phytic acid modified cements had strengths in the range 16–18 MPa.
Corresponding XRD patterns (Figure 2A,B) showed that the reference cement formed newberyite
(MgHPO4·3H2O). Comparing the initial XRD patterns to the patterns after 7 d, quantitative differences
could not be seen for phytic acid containing cements and no further crystalline phase has formed.
Figure 3 reveals the corresponding adhesive strength of various cement formulations on bovine
bone. The blue dotted line marks a strength of 0.2 MPa which was determined 1984 by Weber and
Chapman [27] to be a threshold value for bone-bonding agents. Adhesives with a lower strength would
not be feasible during surgery [27]. Initially, all samples showed an appropriate adhesiveness on bone
between 0.75 ± 0.20 (reference) to 1.22 ± 0.41 MPa (25.0%). Samples with the lowest phytic acid content
represented an exception, as their adhesiveness laid underneath the as-mentioned threshold value.
After ageing, only the composition with a 25.0% phytic acid amount had an appropriate adhesiveness
of 0.81 ± 0.12 MPa still after 7 d. With this composition, it was possible to fix a manually broken porcine
cadaver mandible such that after 10 min the bonding slit withstood the weight of the heavier part as
demonstrated in Figure 3B.
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Figure 1. Compressive strength of cement cuboids made from farringtonite and 2.0 M phosphoric acid
(reference) respectively 20.0, 22.5 or 25.0% phytic acid initially or after 24 h respectively 7 d hardening
in PBS at 37 ◦C.
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Figure 2. Corresponding XRD patterns initially (A) respectively after 7 d (B) hardening of the cement
prepared at a powder-to-liquid ratio of 2.0 g/mL. Characteristic reflexes are marked with f (farringtonite,
PDF-No. 33-0876) respectively n (newberyite, PDF-No. 35-0780) in comparison to JCPDS references.
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Figure 3. (A) Shear strength of cem nt adhesives made from farringtonite and either 2.0 phos i
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7 d hardening in PBS at 37 ◦C on bovine cortical bone substrates. (B) porcine mandible which was
manually broken and fixed with 25% phytic acid bone adhesive. The arrows mark the beginning and
end of the bonding slit.
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Possible adhesive residues on bone surfaces were verified via EDS measurements (Figure 4),
whereas Mg mainly stems from cement residues and Ca from the bone substrate. A quantitative
analysis regarding the Ca-to-Mg-ratio of cement residues and the adherend area is displayed in Table 1.
For all cements, initially a calcium: magnesium ratio in the range of ~3.0–7.3 was found on the adherend
surfaces, which increased over 7 days to values between 5.6–9.9. Even the latter indicates still a higher
amount of Mg2+ to be present in the adherend surface (mostly inside the scrub marks which derived
from bone substrate preparation, Figure 3A) compared to native bone with a Mg content of ~0.72 wt.%
(corresponding to a Ca:Mg ratio of ~55) [28]. Also, whole cement fragments were found in this area for
both the newberyite reference and the phytic acid-based adhesives, whereby gradually less cement
residues were found on the bone surface after ageing.
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Figure 4. Examples of EDS element maps of cement adhesives made from fa ringtonite and either 2.0
phosphoric acid (reference) or 25.0 phytic acid initia ly or after 7 d hardening in PBS at 37 ◦C on
ground bovine bone sa ples. A l cements were prepared in a powder-to-liquid ratio of 2.0 g/mL. The
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Table 1. Ca-to-Mg-ratio on cement and adherend of the different bone adhesive samples. Concentrations
of Ca and Mg were calculated based on corresponding EDS element maps. The ratios of one row derive
each from the same (border) EDS element map (Figure 4).
Ca-to-Mg-Ratio (wt.%/wt.%)
Phytic Acid (%) Time Cement Residues Adherend
0 initial 0.23 ± 0.02 3.0 ± 0.2
24 h 0.31 ± 0.03 2.7 ± 0.2
7 d 1.6 ± 0.1* 5.6 ± 0.5
20.0 initial 0.08 ± 0.01 4.9 ± 0.5
24 h 0.20 ± 0.02 4.7 ± 0.2
7 d 0.42 ± 0.05 8.8 ± 0.7
22.5 initial 0 ± 0 6.2 ± 0.5
24 h 0.17 ± 0.02 8.8 ± 0.9
7 d 0.51 ± 0.04 8.3 ± 0.6
25.0 initial 0.01 ± 0.01 7.3 ± 0.8
24 h 0.11 ± 0.01 3.9 ± 0.3
7 d 0.26 ± 0.02 9.9 ± 0.8
* barely complete cement residues visible.
4. Discussion
Conventional calcium phosphate cements (CPC) are considered to be inappropriate for an
application as bone adhesives [15]. Indeed, calcium phosphates (CaP) are described as osteo-inductive
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materials, which indicates their ability to induce bone formation at heterotopic defect sites [29] and
when implanted in cortical bone, a narrow contact between a hydroxyapatite forming CPC and bone
was observed [30,31]. However, an instant bone-bonding which would be desirable for their use as
bone adhesives is not the case [31]. Barely examples are known in the field of CPC, which directly
prove their ability to adhere on bone surfaces. Grover et al. [31] substituted orthophosphoric by
pyrophosphoric acid in a brushite forming cement system to improve its bonding on cortical bone and
on different biomaterial surfaces [31]. More attempts to enlarge the application field of CaP towards
bone adhesives focused on the incorporation of ceramic particles e.g., monocalcium phosphate [19] or
β-tricalcium phosphate [18–20] into biodegradable methacrylated polylactide-based adhesives [18–20].
However, because of their similarity to the mineral phase of bone [15,32], CPC are still promising for
applications, where bone-bonding is required [15].
In general, magnesium phosphate cements (MPC) seem to have the higher bonding
potential [15] as they were already used in an adhesive manner in vivo for a successfully improved
tendon-to-bone-healing [33] and it was shown that MPC are more effective in stabilizing bone fragments
to native bone compared to CPC [22]. Gulotta et al. [33] exemplary used a commercially available
MPC [20] which was composed of reactive MgO, potassium as well as sodium phosphate and tricalcium
phosphate. Though, this formulation has not been approved as bone adhesive so far [15].
In the present study, we used diluted phytic acid as the liquid component of an MPC system to
further improve its adhesiveness on bone. The naturally deriving phytic acid is known to strongly
bind polyvalent cations as Ca2+ [24,25] and Mg2+ [25] which are the main constituents of bone and our
adhesive. The cement powder mainly consisted of farringtonite, which has recently been demonstrated
to react with phytic acid, and 6.0, 6.8 or 7.5 wt.% MgO. The latter was necessary to adjust a proper
hardening time as it is a highly reactive source of Mg2+ and counteracts the retarding effect that has
been observed for phytic acid in combination with mineral bone cements before Christel [23]. Using
this approach, it was possible to demold the adhesive-surface constructs already after 10 min and
even a fixed porcine cadaver mandible was able to carry its own weight without fracturing after this
time (Figure 3B). Measuring the inherent strength of the cements revealed that the setting reaction
further proceeds afterwards and reached values around 16−21 MPa for the phytic acid containing
samples and 8 MPa for the newberyite reference after 24 h (Figure 1), which is in the range and after
longer immersion even superior to the compressive strength of human cancellous bone [34] and similar
to MPC obtained by the reaction of farringtonite with acid monocalcium phosphate [35]. While the
setting reaction with 2 M phosphoric acid led to a rapid formation of newberyite in the reference
cements paste (Figure 2A), no crystalline phases were formed with phytic acid and even prolonged
post-curing in water did not lead to a distinct conversion from farringtonite into newberyite as shown
by corresponding XRD patterns (Figure 2B).
The adhesive strength determined for our MPCs was initially ~0.75 MPa for the newberyite
control and ~1.22 MPa for 25% phytic acid cement. Overall, a mixed adhesive–cohesive failure was
observed with remaining cement fragments and particles on the surface and within the scrubs resulting
from grinding the bone samples. All samples showed an effect of ageing over a course of 7 d, and the
25% phytic acid adhesive still exceeded the minimal strength of 0.2 MPa necessary for a bone adhesive
as proposed by Weber and Chapman [27]. Using a mineral bone cement, Grover et al. [31] observed
an initial adhesive strength of 1.3 ± 0.8 MPa on ovine cortical bone which is comparable to what we
reached with 25% phytic acid containing samples. We tested the bone-bonding properties on ground
bone slices, but did not remove natural impurities as fats and proteins, whereas the bone samples of
the as-mentioned publication [31] were defatted prior to bond fabrication. Furthermore, our long-term
experiments were performed in a wet and not just humid environment which also can impair the
actual bonding strength, but better reflects in vivo conditions. The upper limit of described adhesion to
bone is ~14 MPa using a 4-methacryloyloxyethyl trimellitic anhydride/methyl methacrylate adhesive
as an interface between human cortical femur and poly(methyl methacrylate) [15,36], but the lack of
biodegradability for this system is crucial [15].
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5. Conclusions
Mineral bone cements are barely tested in vitro for their application as bone-bonding agents
and are mostly considered to be non-suitable. In the present study, we showed that a magnesium
phosphate cement with unconventional setting mechanism could yet be used as an adhesive on
bone, since adhesive strengths of > 0.8 MPa were obtained even after 7 d ageing in a physiological
model environment. Although just tested in a proof-of-principle manner with a selected number of
experiments, the results indicate that moisture plays a crucial role for the in vitro bonding character.
Furthermore, the nature of the adhesive effect has to be investigated in more detail, e.g., is the chelating
effect of the phytate ions by its own responsible or is it a combination of the acidic pH of the cements
with chelation that improves adhesion. This will help to further improve the described mineral
adhesives by design. Although the principal in vitro biocompatibility of phytic acid modified cements
has been demonstrated before [37], an application as adhesive must also ensure that the materials
will be degraded without impairing bone healing in the fracture gap. However, it is not possible
to answer this aspect in pure in vitro experiments as simultaneous material degradation and bone
healing is a complicated biological process with a range of different cell types (osteoclast, osteoblasts,
macrophages) being involved. After this has been demonstrated, the cements from this study will
have the potential to be applied in various clinical scenarios, e.g., midface and orbital fractures or even
comminuted cranial fractures. For all cases, only moderate mechanical properties of adhesives are
required to arrange small bone fragments into larger structures, which are subsequently fixed by plates
and screws to bear mechanical load.
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